Article

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipids

2025-12-02

Abstract excerpt

<h4>Background</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD) is among the most prevalent liver disorders in Western countries. While hepatic steatosis is prevalent, molecular mechanisms associated with steatosis grades and how nutrition modulates related metabolic disturbances remain poorly understood. <h4>Methods</h4> We quantified 175 metabolites and lipids and 148 proteins in serum sam...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a0a18d84-7a13-5849-b8bf-b960f68059a9
DOI: 10.64898/2025.12.01.25341334

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of liver steatosis through circulating proteins, metabolites and lipidsDOI 10.64898/2025.12.01.25341334Read

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read

Global molecular landscape of early MASLD progression in obesitySemantic proximity Read

Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver diseaseSemantic proximity Read

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read

A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverSemantic proximity Read

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future PerspectivesSemantic proximity Read

Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in ArgentinaSemantic proximity Read

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Semantic proximity Read